TNFSF4 and autoimmune disease: Similar phenomena have been showed in OX40L (or OX40 agonist) treated autoimmune disorders, which administration of OX40 agonist before the onset of the disease can increase Tregs and delay the onset of the disease, while treatment near onset day can exacerbate the disease[51].